Lung Cancer

Share

Program Content

Activities

  • Conference to Clinic: Lung Cancer
    Conference to Clinic: Lung Cancer
    Conference Coverage
    Slideset
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 16, 2023

  • Conference to Clinic: Lung Cancer
    Conference to Clinic: Expert Analysis of the Top Lung Cancer Abstracts From the 2023 Oncology Meeting in Chicago
    Video
    Congratulations: You achieved a completion on 04/09/2022

    Released: June 29, 2023

    Expires: June 28, 2024

  • Lung Cancer Highlights: ASCO 2023
    Key Studies in Lung Cancer: Independent Conference Coverage of ASCO 2023
    Conference Coverage
    Text Module
    Congratulations: You achieved a completion on 04/09/2022

    Released: August 25, 2023

    Expires: August 24, 2024

Activities

Neoadjuvant Osimertinib in EGFRm NSCLC
Phase II Trial of Neoadjuvant Osimertinib in Stage I-IIIA EGFR-Mutated NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2023

AGAIN
Phase III AGAIN (JCOG1404/WJOG8214L) Trial: First-line EGFR-TKI Monotherapy vs EGFR-TKI and Inserted Cisplatin/Pemetrexed in Advanced Nonsquamous, EGFR-Mutated NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 05, 2023

NEOTORCH
Phase III NEOTORCH: Interim EFS Analysis of Perioperative Toripalimab + Platinum-Doublet CT vs Platinum-Doublet CT in Resectable Stage II/III NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 06, 2023

Pembro + CT in Pleural Mesothelioma
Phase III Trial of Pembrolizumab + Chemotherapy vs Chemotherapy Alone in Treatment-Naive Pleural Mesothelioma
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 07, 2023

KEYNOTE-671
KEYNOTE-671: Pembrolizumab or Placebo + Platinum-Based Neoadjuvant Chemotherapy Followed by Resection and Adjuvant Pembrolizumab or Placebo in Early-Stage NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2023

CheckMate 9LA: 4-Yr Update
CheckMate 9LA: 4-Yr Update of First-line Nivolumab + Ipilimumab + CT vs CT Alone in Advanced NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2023

TROPION-Lung02
TROPION-Lung02: Datopotamab Deruxtecan + Pembrolizumab ± Platinum Chemotherapy in Advanced NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 08, 2023

KEYNOTE-789
Phase III KEYNOTE-789: Pemetrexed/Platinum Chemotherapy ± Pembrolizumab in TKI-Resistant, EGFR-Mutated, Metastatic Nonsquamous NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2023

SWOG S1929
Phase II SWOG S1929: Maintenance Atezolizumab ± Talazoparib for SLFN11-Positive Extensive-Stage SCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2023

INSIGHT 2 Trial Results
INSIGHT 2: Tepotinib + Osimertinib for Advanced EGFR-Mutated NSCLC With MET Amplification Following First-line Osimertinib
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2023

ADAURA: Final OS Analysis
ADAURA: OS Analysis of Adjuvant Osimertinib vs Placebo After Complete Resection in Stage IB-IIIA EGFR-Mutated NSCLC
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 09, 2023

LUNAR: TTFields in NSCLC
Phase III LUNAR: Tumor Treating Fields + Standard Second-line Therapy in Metastatic NSCLC With Progression On/After Platinum-Based Therapy
Conference Coverage
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 12, 2023

Faculty

cover img faculity

Karen Reckamp, MD, MS

Director, Division of Medical Oncology
Associate Director, Clinical Research
Clinical Professor, Department of Medicine
Cedars-Sinai
Los Angeles, California

cover img faculity

Heather Wakelee, MD, FASCO

Professor of Medicine
Department of Medicine/Oncology
Stanford University
Stanford University Cancer Institute
Stanford, California 

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from AstraZeneca, Daiichi Sankyo, Merck Sharp & Dohme Corp., and Novocure.

AstraZeneca

Daiichi Sankyo

Merck Sharp & Dohme Corp.

Novocure